-
CureVac sues Moderna in Delaware over Spikevax patents, seeking treble damages but no injunction
Read more: CureVac sues Moderna in Delaware over Spikevax patents, seeking treble damages but no injunctionCureVac sues Moderna for treble damages but not an injunction over 10 patents related to Spikevax. The case adds to broader post-COVID mRNA patent battles.
-
Disney faces clear and present danger of UPC 11-country HEVC patent injunction in InterDigital case after May 5 & 6 hearing: court document
Read more: Disney faces clear and present danger of UPC 11-country HEVC patent injunction in InterDigital case after May 5 & 6 hearing: court documentThe UPC Mannheim LD appears unconvinced of Disney’s technical defenses, and even if the court deemed Disney entitled to a FRAND license, an injunction would probably issue.
-
IP Bridge’s Geely injunction stayed in Brazil; GWM proceedings show ongoing enforcement
Read more: IP Bridge’s Geely injunction stayed in Brazil; GWM proceedings show ongoing enforcementPreliminary injunction-related developments in Brazil’s SEP disputes have been prematurely characterized as a shift against strong enforcement. A temporary appellate measure is not a final reversal, and parallel proceedings against GWM are ongoing.
-
ECJ Advocate General says excipient label is binding for SPC purposes: Halozyme v. Czech IPO
Read more: ECJ Advocate General says excipient label is binding for SPC purposes: Halozyme v. Czech IPOAG Emiliou says a substance in a MA that is called an excipient may not be considered an active ingredient for SPC purposes, which would invalidate grants in eight EU member states.
-
UPC CD Paris says expired BASF patent still open to attack, makes own determination of technical problem
Read more: UPC CD Paris says expired BASF patent still open to attack, makes own determination of technical problemThe UPC’s CD Paris dismissed Huntsman’s revocation action against BASF’s expired EP1516720, confirming that expired patents may still be challenged where past-damage exposure remains live.
-
Toyota acquires patents from LG as it looks to expand its licensor role, including in Avanci pools
Read more: Toyota acquires patents from LG as it looks to expand its licensor role, including in Avanci poolsThe Japanese automaker had previously acquired mobile-related patents from China’s OPPO.
-
Quantificare v. Canfield Scientific: Dusseldorf LD finds infringement across four UPC states, rejects invalidity counterclaim
Read more: Quantificare v. Canfield Scientific: Dusseldorf LD finds infringement across four UPC states, rejects invalidity counterclaimThe UPC’s Dusseldorf LD ruled that a confirmed infringing act in one contracting member state is enough to support a pan-UPCland injunction, even where the only provable act is in a country the patent holder deliberately carved out of its claim.
-
English appeals court presses Acer, ASUS on refusal to arbitrate Nokia licensing terms; UPC’s PMAC mentioned as one option
Read more: English appeals court presses Acer, ASUS on refusal to arbitrate Nokia licensing terms; UPC’s PMAC mentioned as one optionComputer makers Acer and ASUS have a credibility problem with respect to their willingness to take a FRAND license. Nokia’s only problem is the state of English SEP case law.
Follow Us
Latest Articles
- CureVac sues Moderna in Delaware over Spikevax patents, seeking treble damages but no injunction
- Disney faces clear and present danger of UPC 11-country HEVC patent injunction in InterDigital case after May 5 & 6 hearing: court document
- IP Bridge’s Geely injunction stayed in Brazil; GWM proceedings show ongoing enforcement
- ECJ Advocate General says excipient label is binding for SPC purposes: Halozyme v. Czech IPO
- UPC CD Paris says expired BASF patent still open to attack, makes own determination of technical problem